Journal Article

DNA repair polymorphisms and cancer risk in non-smokers in a cohort study

G. Matullo, A.M. Dunning, S. Guarrera, C. Baynes, S. Polidoro, S. Garte, H. Autrup, C. Malaveille, M. Peluso, L. Airoldi, F. Veglia, E. Gormally, G. Hoek, M. Krzyzanowski, K. Overvad, O. Raaschou-Nielsen, F. Clavel-Chapelon, J. Linseisen, H. Boeing, A. Trichopoulou, D. Palli, V. Krogh, R. Tumino, S. Panico, H.B. Bueno-De-Mesquita, P.H. Peeters, E. Lund, G. Pera, C. Martinez, M. Dorronsoro, A. Barricarte, M.J. Tormo, J.R. Quiros, N.E. Day, T.J. Key, R. Saracci, R. Kaaks, E. Riboli and P. Vineis

in Carcinogenesis

Volume 27, issue 5, pages 997-1007
Published in print May 2006 | ISSN: 0143-3334
Published online November 2005 | e-ISSN: 1460-2180 | DOI:
DNA repair polymorphisms and cancer risk in non-smokers in a cohort study

More Like This

Show all results sharing this subject:

  • Clinical Cytogenetics and Molecular Genetics


Show Summary Details


Environmental carcinogens contained in air pollution, such as polycyclic aromatic hydrocarbons, aromatic amines or N-nitroso compounds, predominantly form DNA adducts but can also generate interstrand cross-links and reactive oxygen species. If unrepaired, such lesions increase the risk of somatic mutations and cancer. Our study investigated the relationships between 22 polymorphisms (and their haplotypes) in 16 DNA repair genes belonging to different repair pathways in 1094 controls and 567 cancer cases (bladder cancer, 131; lung cancer, 134; oral–pharyngeal cancer, 41; laryngeal cancer, 47; leukaemia, 179; death from emphysema and chronic obstructive pulmonary disease, 84). The design was a case–control study nested within a prospective investigation. Among the many comparisons, few polymorphisms were associated with the diseases at the univariate analysis: XRCC1-399 Gln/Gln variant homozygotes [odds ratios (OR) = 2.20, 95% confidence intervals (CI) = 1.16–4.17] and XRCC3-241 Met/Met homozygotes (OR = 0.51, 95% CI = 0.27–0.96) and leukaemia. The recessive model in the stepwise multivariate analysis revealed a possible protective effect of XRCC1-399Gln/Gln in lung cancer (OR = 0.22, 95% CI = 0.05–0.98), and confirmed an opposite effect (OR = 2.47, 95% CI = 1.02–6.02) in the leukaemia group. Our results also suggest that the XPD/ERCC1-GAT haplotype may modulate leukaemia (OR = 1.28, 95% CI = 1.02–1.61), bladder cancer (OR = 1.38, 95% CI = 1.06–1.79) and possibly other cancer risks. Further investigations of the combined effects of polymorphisms within these DNA repair genes, smoking and other risk factors may help to clarify the influence of genetic variation in the carcinogenic process.

Keywords: AP, apurinic/apyrimidinic; BER, base excision repair; CA, chromosomal aberrations; CI, confidence interval; COPD, chronic obstructive pulmonary disease; DHPLC, denaturing high performance liquid chromatography; DRC, defect repair capacity; DSB, double strand break; EPIC, European Prospective Investigation into Cancer and Nutrition; ETS, environmental tobacco smoke; FPRP, false positive report probability; IARC, International Agency for Research on Cancer; LD, linkage disequilibrium; MDMT, methylguanine-DNA methyltransferase; MMR, Mismatch repair; NER, nucleotide excision repair; OR, odds ratio; PE, primer extension technique; SNP, single nucleotide polymorphism; SSB, single strand break; UADC, upper aero-digestive cancer

Journal Article.  8010 words. 

Subjects: Clinical Cytogenetics and Molecular Genetics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.